Evidence map›Paper›PMID 39333878›Full record

ArticleBMC neuroscience2024

Thymoquinone ameliorate oxidative stress, GABAergic neuronal depletion and memory impairment through Nrf2/ARE signaling pathway in the dentate gyrus following cypermethrin administration.

Abubakar Lekan Imam, Akeem Ayodeji Okesina, Fatimo Ajoke Sulaimon, Aminu Imam, Ruqayyah Yetunde Ibiyeye, Lukuman Aboyeji Oyewole, Sikiru Abayomi Biliaminu, Monsur Shehu, Abdulhameed Oluwatomi Alli, Oluwatosin Olasheu Omoola and 1 more

Abstract read
In one paragraph

Article in BMC neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Antiepileptic and antiepileptogenic effects ofIBRO neuroscience reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Analysis of Pharmacological Properties ofLife (Basel, Switzerland) · 2025
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abubakar Lekan ImamDepartment of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
Akeem Ayodeji OkesinaDepartment of Clinical Medicine and Community Health, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda. akeemokesina@gmail.com.ORCID 0000-0003-3238-6676
Fatimo Ajoke SulaimonDepartment of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
Aminu ImamDepartment of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
Ruqayyah Yetunde IbiyeyeDepartment of Anatomy, Faculty of Basic Medical Sciences, College of Health Sciences, Kwara State University, Malete, Nigeria.
Lukuman Aboyeji OyewoleDepartment of Physiology, Faculty of Basic Medical Science, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Sikiru Abayomi BiliaminuDepartment of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.
Monsur ShehuDepartment of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.
Abdulhameed Oluwatomi AlliDepartment of Science Laboratory Technology, Kwara State Polytechnic, Ilorin, Kwara State, Nigeria.
Oluwatosin Olasheu OmoolaDepartment of Human Anatomy, Faculty of Biomedical Sciences, Kampala International University, Western Campus, Ishaka/Bushenyi, Uganda.
Salihu Moyosore AjaoDepartment of Anatomy, Faculty of Basic Medical Sciences, University of Ilorin, Ilorin, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExposure to chemical toxins, including insecticides, harms bodily organs like the brain. This study examined the neuroprotective of thymoquinone on the cypermethrin's harmful effects on the histoarchitecture of the dentate gyrus and motor deficit in the dentate gyrus.

methodsForty adult male rats (180-200 g) were randomly divided into 5 groups (n = 8 per group). Groups I, II, III, IV, and V received oral administration of 0.5 ml of phosphate-buffered saline, cypermethrin (20 mg/kg), thymoquinone (10 mg/kg), cypermethrin (20 mg/kg) + thymoquinone (5 mg/kg), and cypermethrin (20 mg/kg) + thymoquinone (10 mg/kg) for 14 days respectively. The novel object recognition test that assesses intermediate-term memory was done on days 14 and 21 of the experiment. At the end of these treatments, the animals were euthanized and taken for cytoarchitectural (hematoxylin and eosin; Cresyl violet) and immunohistochemical studies (Nuclear factor erythroid 2-related factor 2 (Nrf2), Parvalbumin, and B-cell lymphoma 2 (Bcl2).

resultThe study shows that thymoquinone at 5 and 10 mg/kg improved Novelty preference and discrimination index. Thymoquinone enhanced Nissl body integrity, increased GABBAergic interneuron expression, nuclear factor erythroid 2-derived factor 2, and enhanced Bcl-2 expression in the dentate gyrus. It also improved the concentration of nuclear factor erythroid 2-derived factor 2, increased the activities of superoxide dismutase and glutathione, and decreased the concentration of malondialdehyde level against cypermethrin-induced neurotoxicity.

conclusionthymoquinone could be a therapeutic agent against cypermethrin poisoning.

Indexed as

BenzoquinonesDentate GyrusGABAergic NeuronsMemory DisordersNF-E2-Related Factor 2Oxidative StressPyrethrinsSignal TransductionAnimalsInsecticidesMaleNeuroprotective AgentsRatsRats, WistarBenzoquinonescypermethrinInsecticidesNeuroprotective AgentsNfe2l2 protein, ratNF-E2-Related Factor 2PyrethrinsthymoquinoneCresyl fast violetCypermethrinDentate gyrusGABBAergic interneuronThymoquinone

Identifiers

PMID39333878
PMCPMC11428341

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.